Lai palielinātu vai samazinātu teksta burtu izmēru, izmantojiet šādas klaviatūras taustiņu kombinācijas: 
Current Research and Project Agreements
| Title | Clinic | Ethics Committee approval | |
| Understanding risk factors associated with lung cancer and assessment of their impact | Thoracic Surgery and Interventional Pulmonology Clinic; Pulmonology Clinic | Central Medical Ethics Committee permit No. 01-29.1.2/413 | |
| Selection and preparation of mammographic images for research and educational purposes, including the EUCAIM research project | Radiology Centre; Oncological Surgery Clinic | Ethics Committee opinion of the Support Foundation for Medical and Biomedical Research of Rīgas Austrumu klīniskā universitātes slimnīca No. 12-A/25 | |
| Biomarkers of lung damage associated with tuberculosis-related chronic obstructive pulmonary disease | Pulmonology Clinic |
|
| Bronchiectasis Research Involving Databases, Genomics and Endotyping (BRIDGE) | Department of Internal Medicine |
|
| Functional liquid biopsies for the detection and monitoring of cancer (FLUID-C) | Operating Unit (LOC); Oncology Surgery Clinic; Pathology Centre; Laboratory Service | Opinion of the Central Medical Ethics Committee No. 01-29.1.2/536 |
| Non-invasive diagnostic and predictive biomarkers for bladder tumor early diagnosis and prediction | Clinic of Urology and Oncological Urology | Opinions of the Central Medical Ethics Committee No. 01-29.1.2/1352 and No. 01-29.1.2/534 |
| Multimodal optic imaging for diagnosis of personalized microcirculation hemodynamic phenotype in septic patients | Intensive Care Clinic | Opinion No. 13-22/112 of the Ethics Committee for Life and Medical Sciences Research of the University of Latvia |
| The Role of Fatty Acid Metabolism in Cancer Cell Development | Oncology Surgery Clinic; Neurology and Neurosurgery Clinic | Opinion No. 20-A/25 of the Medical and Biomedical Research Ethics Committee of the Support Foundation of Riga East University Hospital |
| TAD disruption and aberrant expression as leukemia metabolic vulnerabilities for novel combination therapy tests in a drug screening platform (TOSCANINI) | Hematology Clinic | Opinion No. 02-A/26 of the Medical and Biomedical Research Ethics Committee of the Support Foundation of Riga East University Hospital |
